| |
| |
|
| Insider
Information: |
Pruitt Michael |
| Relationship: |
|
| City: |
Charlotte |
| State: |
NC |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
1,034,629 |
|
|
Indirect Shares
|
1,365,194 |
|
|
| Direct
Value |
$13,632 |
|
|
|
Indirect Value
|
$28,284 |
|
|
| Total
Shares |
2,399,823 |
|
|
| Total
Value |
$41,916 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
0
|
|
Stock
price went up :
|
2
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
2.0
|
0.0
|
| Percentage
Gain/Loss : |
 42.3%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Onetravel Holdings Inc |
OTVLQ |
Vice Chairman, Director |
2004-05-27 |
989,565 |
2005-05-26 |
1,329,392 |
Premium* |
|
|
Sonnet Biotherapeutics Holdings ... |
SONN |
CEO, Chairman, Director |
2020-03-23 |
17,256 |
2020-03-23 |
35,802 |
Premium* |
|
|
Green St Energy Inc |
GSTY |
Director |
2008-12-31 |
9,000 |
|
0 |
Premium* |
|
|
Imac Holdings Ord Shs |
BACK |
Director |
2023-12-20 |
8,808 |
|
0 |
Premium* |
|
|
Fresh Vine Wine, Inc. |
VINE |
|
2022-03-02 |
10,000 |
2022-03-02 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
115 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| OTVLQ |
Onetravel Holdings Inc |
Chief Executive Officer |
• • – |
2003-11-26 |
4 |
B |
$2.30 |
$691 |
I/I |
300 |
1,301,299 |
2.58 |
- |
|
| SONN |
Sonnet Biotherapeutics Ho... |
Chief Executive Officer |
• • • |
2011-06-17 |
4 |
B |
$2.99 |
$897 |
I/I |
300 |
60,680 |
2.56 |
- |
|
| SONN |
Sonnet Biotherapeutics Ho... |
Chief Executive Officer |
• • • |
2011-06-27 |
4 |
B |
$2.69 |
$807 |
I/I |
300 |
60,980 |
2.56 |
- |
|
| SONN |
Sonnet Biotherapeutics Ho... |
Chief Executive Officer |
• • • |
2011-07-05 |
4 |
B |
$2.99 |
$897 |
I/I |
300 |
62,380 |
2.56 |
- |
|
| SONN |
Sonnet Biotherapeutics Ho... |
Chief Executive Officer |
• • • |
2011-07-21 |
4 |
B |
$2.99 |
$897 |
I/I |
300 |
62,680 |
2.56 |
- |
|
| SONN |
Sonnet Biotherapeutics Ho... |
CEO/President |
• • – |
2014-05-28 |
4 |
B |
$2.04 |
$612 |
I/I |
300 |
35,710 |
2.58 |
- |
|
| SONN |
Sonnet Biotherapeutics Ho... |
CEO, Chairman |
• • – |
2016-12-29 |
4 |
B |
$0.43 |
$129 |
I/I |
300 |
7,900 |
2.58 |
- |
|
| SONN |
Sonnet Biotherapeutics Ho... |
CEO, Chairman |
• • – |
2017-01-03 |
4 |
B |
$0.40 |
$120 |
I/I |
300 |
8,200 |
2.58 |
- |
|
| SONN |
Sonnet Biotherapeutics Ho... |
CEO, Chairman |
• • – |
2018-09-12 |
4 |
A |
$2.34 |
$702 |
I/I |
300 |
12,062 |
0 |
- |
|
| SONN |
Sonnet Biotherapeutics Ho... |
Chief Executive Officer |
• • – |
2013-01-23 |
4 |
A |
$1,060.00 |
$424,000 |
D/D |
400 |
204,161 |
0 |
- |
|
| SONN |
Sonnet Biotherapeutics Ho... |
CEO, Chairman |
• • – |
2016-09-28 |
4 |
B |
$0.58 |
$232 |
I/I |
400 |
6,200 |
2.58 |
- |
|
| SONN |
Sonnet Biotherapeutics Ho... |
CEO, Chairman |
• • – |
2016-11-28 |
4 |
B |
$0.54 |
$217 |
I/I |
400 |
7,600 |
2.58 |
- |
|
| SONN |
Sonnet Biotherapeutics Ho... |
CEO, Chairman |
• • – |
2018-11-16 |
4 |
B |
$1.94 |
$776 |
I/I |
400 |
12,462 |
2.58 |
- |
|
| SONN |
Sonnet Biotherapeutics Ho... |
Chief Executive Officer |
• • • |
2009-09-18 |
4 |
B |
$2.50 |
$1,250 |
D/D |
500 |
169,615 |
3.15 |
- |
|
| SONN |
Sonnet Biotherapeutics Ho... |
Chief Executive Officer |
• • • |
2010-04-23 |
4 |
B |
$3.75 |
$1,875 |
I/I |
500 |
2,250 |
2.56 |
- |
|
| SONN |
Sonnet Biotherapeutics Ho... |
Chief Executive Officer |
• • • |
2010-04-28 |
4 |
B |
$4.00 |
$2,000 |
I/I |
500 |
2,750 |
2.56 |
- |
|
| SONN |
Sonnet Biotherapeutics Ho... |
Chief Executive Officer |
• • • |
2010-05-17 |
4 |
B |
$4.15 |
$2,075 |
I/I |
500 |
3,250 |
2.56 |
- |
|
| SONN |
Sonnet Biotherapeutics Ho... |
Chief Executive Officer |
• • • |
2010-06-03 |
4 |
B |
$4.00 |
$2,000 |
I/I |
500 |
3,750 |
2.56 |
- |
|
| SONN |
Sonnet Biotherapeutics Ho... |
Chief Executive Officer |
• • • |
2010-06-11 |
4 |
B |
$4.10 |
$2,050 |
I/I |
500 |
4,250 |
2.56 |
- |
|
| SONN |
Sonnet Biotherapeutics Ho... |
Chief Executive Officer |
• • • |
2010-06-24 |
4 |
B |
$3.75 |
$1,875 |
I/I |
500 |
4,750 |
2.56 |
- |
|
| SONN |
Sonnet Biotherapeutics Ho... |
Chief Executive Officer |
• • • |
2010-08-10 |
4 |
B |
$3.74 |
$1,870 |
I/I |
500 |
22,047 |
2.56 |
- |
|
| SONN |
Sonnet Biotherapeutics Ho... |
Chief Executive Officer |
• • • |
2011-03-24 |
4 |
B |
$3.20 |
$1,600 |
I/I |
500 |
45,094 |
2.56 |
- |
|
| SONN |
Sonnet Biotherapeutics Ho... |
Cheif Executive Officer |
• • – |
2012-07-12 |
4 |
A |
$2,000.00 |
$1,000,000 |
D/D |
500 |
203,305 |
0 |
- |
|
| SONN |
Sonnet Biotherapeutics Ho... |
Chief Executive Officer |
• • – |
2013-04-04 |
4 |
B |
$1.76 |
$880 |
I/I |
500 |
35,410 |
2.58 |
- |
|
| SONN |
Sonnet Biotherapeutics Ho... |
CEO, Chairman |
• • – |
2016-06-06 |
4 |
B |
$0.50 |
$251 |
I/I |
500 |
500 |
2.58 |
- |
|
115 Records found
|
|
Page 2 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
